Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Latest Advances in
Sarcoidosis
Overview
Find a Doctor
Latest Advances
Clinical Trials
Latest Advances
Condition:
Severe Sarcoidosis
Journal:
International journal of environmental research and public health
Treatment Used:
Tailored Exercise
Number of Patients:
1
Published —
December 23, 2020
The study researched the outcomes of tailored exercise for severe sarcoidosis.
Condition:
Sarcoidosis
Journal:
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
Treatment Used:
Methotrexate (MTX)
Number of Patients:
1606
Published —
December 02, 2020
This review of patients evaluated the long-term safety and effectiveness of methotrexate (MTX) as a second line treatment for patients with sarcoidosis (granuloma disease).
Condition:
Sjögren's Syndrome-Related Interstitial Lung Disease
Journal:
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
Treatment Used:
Mycophenolate Treatment
Number of Patients:
19
Published —
October 23, 2020
The study researched the effects of mycophenolate treatment for treating primary Sjögren's syndrome-related interstitial lung disease.
Condition:
Idiopathic Pulmonary Fibrosis
Journal:
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
Treatment Used:
Walk-Bike
Number of Patients:
23
Published —
October 23, 2020
The aim of this study was to evaluate the feasibility of a homebased walk-bike intervention in idiopathic pulmonary fibrosis (IPF) patients and to explore the effect of the walk-bike on quality of life (QoL) and exercise capacity.
Condition:
Sarcoidosis-Associated Pulmonary Hypertension (SAPH)
Journal:
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
Treatment Used:
Macitentan
Number of Patients:
6
Published —
October 23, 2020
This case series describes patients diagnosed with sarcoidosis (granuloma disease)-associated pulmonary hypertension (high blood pressure; PH) treated with macitentan.
Condition:
Idiopathic Pulmonary Fibrosis
Journal:
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
Treatment Used:
Pirfenidone
Number of Patients:
128
Published —
October 23, 2020
In this study, researchers evaluated the safety and effectiveness of pirfenidone for the treatment of idiopathic pulmonary fibrosis.
Condition:
Idiopathic Pulmonary Fibrosis
Journal:
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
Treatment Used:
Pirfenidone
Number of Patients:
0
Published —
October 23, 2020
The purpose of this retrospective observational study was to investigate the response to pirfenidone in idiopathic pulmonary fibrosis (IPF) patients, comparing two groups stratified by the annual rate of decline in forced vital capacity (FVC) % predicted prior to treatment.
Condition:
Sarcoid-Associated Pulmonary Hypertension
Journal:
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
Treatment Used:
Epoprostenol Therapy
Number of Patients:
12
Published —
October 23, 2020
This study evaluated the long term effects of epoprostenol therapy in patients with Sarcoid-Associated Pulmonary Hypertension (SAPH).
Condition:
Obstructive Sleep Apnea in Sarcoidosis
Journal:
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
Treatment Used:
Continuous Positive Airway Pressure Treatment
Number of Patients:
68
Published —
October 23, 2020
The study researched the outcomes of obstructive sleep apnea in sarcoidosis and impact of continuous positive airway pressure treatment on fatigue.
Condition:
COVID-19 with Comorbid Pulmonary Disease
Journal:
Therapeutic advances in respiratory disease
Treatment Used:
Doxycycline
Number of Patients:
4
Published —
September 03, 2020
This case report describes 4 patients with COVID-19 with comorbid pulmonary disease that were treated using doxycycline.
Condition:
First-Generation Metastatic Melanoma
Journal:
Journal of immunology research
Treatment Used:
Ipilimumab
Number of Patients:
17
Published —
August 11, 2020
The purpose of the study was to assess neurocognitive function, psychosocial outcome, health-related quality of life and long-term effects of immune-related adverse events on metastatic melanoma survivors treated with ipilimumab.
Condition:
Ocular Sarcoidosis
Journal:
Seminars in respiratory and critical care medicine
Treatment Used:
Intravitreal Implant, Systemic Corticosteroid, Methotrexate Therapy, Immunosuppression
Number of Patients:
0
Published —
August 11, 2020
The study researched the outcomes and characteristics of ocular sarcoidosis.
Showing 1-12 of 67
Next